摘要
目的探讨异位妊娠药物保守治疗效果及相关影响因素。方法124例异位妊娠患者,采用药物甲氨蝶呤配合米非司酮保守治疗,观察各指标与治疗结局的关系。结果年龄、孕次、产次与治疗结局无相关性(P>0.05)。不同血清β-HCG水平、包块大小、盆腔积液值治疗结局有统计学意义(P<0.01)。血清β-HCG水平、包块大小与治疗成功率呈负相关(P<0.05),为影响保守治疗成功的危险因素(P<0.05,OR>1)。结论血清β-HCG水平、包块大小可作为指导异位妊娠药物保守治疗的参考指标,综合考虑各相关因素以提高治疗成功率。
Objective To investigate the effect and influencing factor in medicine therapy treatment for ectopic pregnancy. Methods All of 124 cases of eetopic pregnancy were treated by medicine therapy, and the relation of clinical indicators and prognosis were analyzed. Results The age, pregnant and fertility times were not related to prognosis （P 〉 0.05）. The prog nosis of different level of serum β-HCG, mass size and pelvic cavity accumulates fluid were significant difference （P 〈 0.01）. The level of serum β-HCG, mass size and treatment success rate were negatively correlated （P 〈 0.05）. The serum β-HCG and mass size were the risk factor of medicine therapy （P 〈 0.05, OR〉1）. Conclusion The serum β-HCG and mass size could be the references in medicine therapy treatment for ectopic pregnancy. Should combine related factors to improve the effect.
出处
《中国现代医生》
2012年第14期41-42,45,共3页
China Modern Doctor
关键词
异位妊娠
甲氨蝶呤
米非司酮
影响因素
Ectopic pregnancy
Methotrexate
Mifepristone
Influencing factor
